Personalis
Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration
Investigators intend to offer Personalis' comprehensive genomics testing to consenting patients for both clinical use and to aggregate data for ongoing research.
In Brief This Week: Biodesix, Avisa Diagnostics, Mount Sinai, Sophia Genetics, and More
News items for the in vitro diagnostics industry for the week of Aug. 23, 2021.
MapKure, Personalis Partner to Screen Patients for BRAF Inhibitor Trial
Personalis plans to develop a companion diagnostic to MapKure's BRAF inhibitor, BGB-3245, once biomarkers have been identified in the study.
Natera, Personalis Team up for Cancer Treatment Monitoring, MRD Testing
Under the non-exclusive deal, Natera will use matched tumor and normal exome sequencing data from Personalis to validate the design of its Signatera ctDNA assays.
Sep 25, 2019